
Health
Fake, unregistered asthma inhalers flood markets after GSK’s exit

A year after British pharmaceutical giant, GlaxoSmithKline exited Nigeria and asthmatic patients who depended on its inhalers faced significant distress due to the medication’s scarcity, investigations showed that fake and unregistered inhalers have flooded Nigerian markets.
For a 28-year-old marketer, Rose Daniel, having to deal with the side effects of an anti-asthmatic tablet, was an experience she never wanted to have anymore.
Every time she took the medicines, uncontrollable tremors sent shivers down her spine, making her lead a less productive life.
But succour came when her consultant, eight years ago, prescribed an asthma preventer, Seretide Diskus inhaler, with zero side effects.
However, following the exit of GSK last year, and the scarcity of the inhalers, the fear of a return to the daily tremors gripped Daniel’s mind.
Determined to spare no cost, the Cross River indigene reached out to notable pharmacies across the country and eventually bought three packs to last her for many months, pending when normalcy would return and the drugs become available.
Once the inhalers became available, Daniel said that she ensured she got her inhalers at a registered pharmacy she was sure sold genuine and approved drugs.
But one day, while at work, she saw the pack of a Seretide inhaler with a colleague and wondered why the pack looked different from hers.
After a quick perusal of the pack, the truth hit her in the face.
“It had no NAFDAC (National Agency for Food and Drug Administration and Control) Registration Number!” she said.
Daniel said she was grateful that she had ensured she had only bought her inhalers and other drugs from a trusted pharmacy store.
On a journey to discovery
Following a tip-off from an asthmatic patient that fake and unregistered inhalers, Seretide inhalers, had flooded the market, PUNCH Healthwise embarked on a fact-finding mission to pharmacies and the drug market in Church Street, Idumota, Lagos State.
Entering into Church Street, the popular hub for wholesale and retail medicines, the tearing sounds of semitransparent adhesive tape (cellotapes) filled the atmosphere.
Human load carriers bore several cartons of purchased medicines and hospital consumables on their back to deliver them to their respective buyers.
After a brief observation of the market nuances, this correspondent inquired at some shops about where to get Seretide Diskus. Then, the referrals began.
A tall, dark-complexioned middle-aged man enthusiastically greeted another man and boldly said in the Yoruba language, “We’ve been in this market since the 1980s.”
This man would later become a guide as he led this correspondent to the prescription shops where the inhaler could be bought.
“If I take you to the place where the other woman described, the price there is expensive, I’ll take you to this shop,” the guide responded.
Unfortunately, the woman at the shop did not sell such a product, leading to another round of referrals.
At last, a young man garbed in native attire, called Nosa, was recommended.
This correspondent then showed him a picture of an unregistered Seretide inhaler, with the pack content written in English and Urdu, a language mostly spoken in Pakistan and India.
After a perusal of the picture, Nosa responded in the affirmative and led us to his ‘second shop’.
Nosa, this correspondent would later learn, sells wholesale and retail prescription medicines.
Curious as to why his name rang through like an anthem on the lips of other sellers, this correspondent asked whether he was the main distributor of Seretide Diskus.
“I am not the only one, I sell prescription medicines,” Nosa opined, as he led us through the noisy market to another shop.
Once we got there, he asked his ‘brother’, Lucky, if the inhaler was available and he responded in the affirmative.
This correspondent was offered a seat on the bench placed by the narrow entrance to the shop to await the return of the salesperson assigned to ‘bring’ the inhaler from an undisclosed location.
Undoubtedly, the unregistered medicines were not to be displayed on the shelves. Only a specific request from a ready-to-pay buyer was the criterion for the inhalers to be brought out.
After about 30 minutes of waiting accompanied by several pleas to be patient, the Seretide Diskus arrived wrapped in a medium-sized black nylon bag.
After checking the content of the bag to be sure “what I ordered was what I got,” this correspondent discovered that the name of the drug was written in Urdu language unlike the one presented.
Throwing further questions at Lucky, he responded, “Every batch comes with a new package but it is from the same producer as the one you showed me. This batch came in English. The one in Urdu was produced last year.”
However, an analysis of the packet showed that it was manufactured by “Glaxo Wellcome Production, France and the Batch Releasing Site: Glaxo Wellcome United Kingdom Limited, Brentford, Middlesex, UK and imported by Modern Pharma Trading Company.”
While the production and expiry dates read January 2024 and January 2026, respectively, the glaring absence of the National Agency for Food and Drug Administration and Control Registration Number rang the alarm bell.
What makes them fake?
In this context, a counterfeit and fake drug is defined by NAFDAC as any drug or drug product which is not registered by the Agency by the provisions of the Food, Drugs and Related Products.
Furthermore, the NAFDAC Drug and Related Product Labelling Regulations, 2019, prohibits the manufacture, import, export, distribution, advertisement and display for sale or use of any drug or drug product that is not labelled by the regulation.
It further reads, “The outer and inner labels of a drug shall clearly show the registration number of the Agency (NAFDAC REG. NO.) assigned to it as indicated on the Certificate of Registration in a manner prescribed by the Agency.”
Any conviction of contravention of the Regulations prescribes the guilty individual to one-year imprisonment or a fine of N50,000 or both and the corporate body to a fine of N100,000.
Providing further insights, the former president of the Pharmaceutical Society of Nigeria, Olumide Akintayo, stated that having fake drugs was a serious offence that violated sections 1.1 and 2.1 of the Fake Drug Acts.
Aside from the violation of the law, Akintayo explained that the influx of fake drugs portends a high incidence of morbidity and mortality rates.
He further discouraged the sale and handling of unregistered drugs and food substances and urged government agencies that have oversight responsibilities to move into action to stem the tide of fake drugs.
The battle for ‘breath’
PUNCH Healthwise had in November 2023, reported the travails of asthmatics, who after GSK’s exit, could no longer find the inhalers.
For those who found them, the astronomical price increase was a burden too heavy to bear, as some of them resorted to using little dosages of the medications for them to last longer, while others bought other brands with cheaper prices.
Lifelong treatment
Although asthma is not curable, inhaled medication, oral and injectable medications can control asthma symptoms, allowing people with asthma to lead normal, productive and active lives.
This made asthmatics use their preventive inhalers daily and go about with the reliever inhalers.
According to the World Health Organisation, asthma is a major non-communicable disease affecting both children and adults but is the most common chronic disease among children.
Asthma symptoms are caused by the inflammation and narrowing of the small airways in the lungs, which can lead to a combination of cough, wheezing, shortness of breath and chest tightness.
As of 2019, the Nigerian Thoracic Society stated that 15 million people were asthmatics. This implies that 15 million out of the over 213 million Nigerians, have asthma.
Many asthmatics use Seretide
The president of the Nigerian Thoracic Society, Professor Musa Babashani, confirmed to PUNCH Healthwise that although alternative controller inhalers were available, many asthmatics in Nigeria rely on Seretide.
With over 13 million Nigerians living with asthma, the NTS president warned that the influx of fake controller inhalers would make it even more difficult for patients to manage their symptoms, potentially leading to higher morbidity and mortality rates.
Curled from PUNCH
Health
There is no confirmed case of diphtheria in Enugu State’

The Enugu State Government says there is no confirmed case of diphtheria in the state, urging residents to disapprove unfounded ongoing rumours.
The Commissioner for Health, Prof George Ugwu, made the clarification in a briefing on Wednesday in Enugu on update on the rumoured suspected case of a diphtheria patient in University of Nigeria Teaching Hospital (UNTH), Ituku/Ozalla, Enugu.
“In response to this, the Public health and Surveillance unit of the State Ministry of Health are already at alert and to ensure appropriate prevention control measure and early detection as may be necessary.
“A few days ago, there was a report of suspected case of diphtheria at the University of Nigeria Teaching Hospital (UNTH), Enugu which was followed by our team.
“However, the diagnosis of diphtheria could not be sustained or confirmed; while the patient, wito was rumoured and suspected to have diphtheria,
had tonsillitis,” he said.
The commissioner noted that accordingly, contact traces and other appropriate measures are ongoing and “yet diphtheria are not diagnosed or confirmed in the state.”
He explained that the suspected patient had been traced to his home in Achara Layout in Enugu and he did not have any record of travel and had not being to the northern part of the country as rumoured.
“Our surveillance and tracing teams have also contacted his family members and others but no trace of diphtheria established,” he said.
Ugwu noted that although the state had remained on high alert against infectious diseases, “Enugu State is never at high risk of contacting diphtheria”.
“For the state, we have a robust routine and mop up vaccination especially on Penta 3, which provides effective immunisation against diphtheria for a whole life time.
“In 2026 Vaccination, we had 91 per cent record of coverage on Penta 3 vaccination, which is even above the national target or threshold,” he said.
The commissioner urged residents to remain calm and avoid spreading rumours or unverified information as well as seek medical attention promptly if they develop symptoms of any sickness.
He said, “The ministry is calling on parents and caregivers to ensure children are fully immunised with diphtheria containing vaccines (Penta 3).
“Residents are urged to follow the advice of health authorities during contact tracing and monitoring.
“Healthcare workers are urged to maintain appropriate standard precautions, promptly notify suspected cases through the surveillance system and ensure appropriate infection prevention and control measures.
“The Enugu State Ministry of Health, in collaboration with UNTH and relevant international partners, continues to monitor the situation and will be proactive for further information as necessary,” he added.
It would be recalled that there is an outbreak of diphtheria in Nigeria and 19,799 suspected cases sent to molecular laboratory test; with 15,309 confirmed cases and 517 confirmed death across 26 states and 357 Local Government Areas.
The worst affected states accounting for over 98 per cent cases of diphtheria are Kano, Bauchi, Borno, Kastin, Sokato, Zamfara, Kaduna and Plateau according to Nigeria Centre for Disease Control and Prevention (NCDC).
Diphtheria is a serious but vaccine preventable bacterial disease that can spread though respiratory droplets and close contact.
Symptoms of Diphtheria include: fever, sore throat, difficulty or pain when swallowing, cough, difficulty breathing, swelling of the neck and greyish/white membrane in the throat.
Health
UNTH Begins Contact Tracing After Suspected Diphtheria Case

The University of Nigeria Teaching Hospital (UNTH), Ituku-Ozalla, Enugu State, has urged patients, visitors and members of the public to remain calm following the management of a clinically suspected case of diphtheria at the hospital.
The reassurance followed concerns over the admission and subsequent death of a paediatric patient at the hospital’s Children’s Emergency Room (CHER).
According to a statement issued by the hospital management on Wednesday, the patient received medical intervention immediately after admission but died two days later despite efforts by the attending medical team.
The hospital said a subsequent clinical post-mortem review suggested that the severe symptoms may have been caused by severe pharyngotonsillitis with massive exudate, rather than diphtheria as initially suspected.
However, as a precautionary measure, UNTH said comprehensive contact tracing had commenced to identify and monitor individuals who may have had close contact with the deceased.
The hospital also confirmed that the Children’s Emergency Room had undergone standard decontamination in line with established infection prevention and control protocols.
UNTH said it had previously managed sporadic cases of diphtheria successfully and possesses the specialist personnel, isolation facilities and medical equipment required to manage infectious disease cases.
The management urged members of the public to remain vigilant for symptoms associated with diphtheria, including persistent fever, severe sore throat and difficulty swallowing.
It advised anyone experiencing such symptoms, as well as parents whose children develop them, to seek immediate medical attention at a recognised healthcare facility and avoid self-medication.
Healthcare workers, patients and visitors were also advised to maintain proper hand hygiene and respiratory etiquette while within the hospital premises.
The hospital management assured the public that it would continue to prioritise community safety and public health, while providing updates based on verified medical information.
Health
Peter Obi, Chinyeaka Ohaa Visit Parklane Hospital in Solidarity With Kidney Patients

ENUGU — The Presidential Candidate of the National Democratic Congress (NDC), Mr Peter Obi, and the party’s Enugu State Governorship Candidate, Sir Chinyeaka Ohaa, on Thursday, August 13, 2026, visited Parklane Specialist Hospital, Enugu, to show solidarity with patients battling kidney disease and other related illnesses.
They arrived at about 5:00 p.m. in the company of other party leaders, including the NDC Senatorial Candidate for Enugu East, Ada Ogbu; Hon. Kentus Eze; Hon. Ike Ezugwu; Architect Everastus Odo; Comrade Obi Mamah, H(JP); Hon. Odo Joel; and other party faithful who turned out to receive Peter Obi.
The visit followed a humanitarian gathering convened by Okwuluora to draw attention to the plight of more than 500 kidney patients and their families struggling to afford treatment.
Over 500 Kidney Patients Cry for Help as Families Battle for Survival
It was an emotional scene as men, women and children living with kidney-related illnesses converged at Parklane, hoping to receive urgent assistance.
Many of the patients showed visible signs of prolonged illness and hardship. Some were due for dialysis but could not afford the treatment, leaving them and their families trapped in a painful struggle for survival.
The severity of their condition was evident, with some displaying swollen hands, arms and legs, while others had bloated abdomens and anxiety-filled faces as they awaited assistance.
Among those present was a 13-year-old boy from Akure, Ondo State. His mother said she had sold virtually everything she owned to sustain his dialysis treatment for the past five years. Despite the sacrifices, the boy was at Parklane hoping to benefit from the intervention.
The large turnout has renewed concerns over the growing burden of kidney disease and the rising cost of dialysis and transplant care in the South-East and other parts of the country.
Speaking at the event, Okwuluora commended the stakeholders who supported the initiative and called for sustained assistance for kidney patients and their families.
The national and state leadership of the NDC also commended Okwuluora for his consistent commitment to Nigerians in need, particularly those battling critical health challenges.
In his remarks, Peter Obi expressed concern after listening to the testimonies of the patients. He called on well-meaning Nigerians, corporate organisations and governments at all levels to support kidney patients in dire need of assistance.
The organisers and families of the patients expressed gratitude to Obi for honouring the invitation and using his platform to draw attention to the plight of sick and vulnerable Nigerians.
They also thanked Sir Chinyeaka Ohaa for standing with the people of Enugu during the difficult moment and for demonstrating what they described as leadership that places human lives first.
Appreciation was equally extended to NDC supporters who attended the gathering, with attendees saying their presence offered hope and reassurance to the patients and their families.
The NDC leadership reaffirmed its commitment to advocating for improved healthcare funding, greater access to dialysis and policies aimed at reducing the burden of catastrophic healthcare expenses on families in Enugu State and across Nigeria.
Health
Enugu pledges commitment to support NCDC to facilitate health security projects, initiatives

Gov. Peter Mbah says Enugu State remains fully ready to support Nigeria Centre for Disease Control and Prevention (NCDC) on health security facilities and projects within the state.
Mbah said this on Wednesday in Enugu when the Director-General of Nigeria Centre for Disease Control and Prevention (NCDC), Dr Jide Idris, paid him a courtesy call during a working visit to the state.
Represented by the Deputy Governor, Chief Ifeanyi Ossai, the governor said that the government had prioritised all issues concerning security especially those dealing on health security and invested heavily on health and related concerns.
According to him, we are fully ready and committed to work with you by providing land, logistics and other necessary requirements to make all health security projects/initiatives a reality.
He said, “We are fully aware of the need to focus and give priority to health security projects and issues.
“As a state, the high volume of travellers coming in their thousands to the state each day have increased our socioeconomic activities, made more investment possible and increased all forms of tourism.
“However, we recognise that only two weeks of a confirmed outbreak of any dreaded disease will scare away these large inflow of people coming into the state.
“This alone will affect and wipe away the striving tourism industry, our people’s vibrant trade and commerce, striving transport ecosystem, investors influx and the huge investment we have put to make Enugu the most attractive city in Africa.”
Mbah said that every effort or investment in health security “is in the right direction to secure our selves, investments, hopes and future.”
The governor commended the NCDC on their recent fight against COVID-19 and all initiatives to ensure prevention of Ebola virus as well as containing other outbreaks in the country.
“I must commend NCDC team for inspecting the ongoing South-East High Definition Molecular Laboratory and other health projects meant to serve our people, South-East and every Nigerian,” he said.
He assured that the government would undertake any responsibility to ensure that NCDC facilities continue running as well as protecting such facilities notwithstanding the premises they are domiciled in within the state.
On the issue of Ebola Virus, the govenor said that the state was taking the designation of Enugu State as a state with high importation risk “very serious”.
“From assessment, the scare of the disease coming to Enugu is real through the Akanu Ibiam International Airport. We are tightening all preventative measures and protocols, while ensuring robust synergy with relevant stakeholders on it.
“The state ministry of health and its partners are on alert over the issue and we are providing necessary support and access to our office on it,” he said.
Mbah called on the NCDC to give the state needed support in terms capacity building and training, close coordination and guidance as well as awareness materials and support in its preventive efforts.
Earlier, Idris said that visit was meant to access uncompleted South-East High Definition Molecular Laboratory, the level of Ebola Prevention and Preparedness at the Akanu Ibiam International Airport and other related projects.
He commended the state government on huge investment in Primary Healthcare Centres, general hospitals, tertiary hospitals and recently the Enugu International Hospital meant to attract medical tourism.
The director-general said that the NCDC wanted the state government to get involved in protecting And maintaining the South-East High Definition Molecular Laboratory and other facilities of the agency coming up in Enugu.
“We are here to strengthen the existing cordial relationship with the state and see how both NCDC and Enugu State Government can collaborate to strengthen issues of health security,” he said.
Health
Enugu, health partners commit to sustain gains of 5-year IntegratE family planning project

The Enugu State Government and key health sector partners have pledged a commitment to sustain the gains of the IntegratE Project.
The IntegratE Project is a five-year family planning initiative that expanded access to reproductive health services through Community Pharmacists (CPs) and Patent and Proprietary Medicine Vendors (PPMVs) within the state.
The Commissioner for Health, Prof. George Ugwu, gave the commitment on Wednesday during the dissemination of the Enugu State Private Sector Family Planning performance under the IntegratE Project, which ran from Oct. 2021 to July 2026.
Ugwu said that the project had significantly improved reproductive health services and positive outcomes for women in the state over the past five years.
He described family planning as a sensitive but essential service, assuring that the government would continue expanding access while ensuring responsible use.
Ugwu said that Gov. Peter Mbah’s administration remained committed to strengthening primary healthcare outcomes in all ramifications
He revealed that more than 100 new primary healthcare centres would become operational before the end of the year.
The commissioner said that the state government’s commitment to innovation would continue to position the state as a leader in modern healthcare delivery.
Speaking, the representative of the Pharmacy Council of Nigeria (PCN), Mrs Ifeyinwa Ohiaeri, described the project as a major intervention that strengthened family planning services through pharmacy practice.
Ohiaeri stressed that “family planning remains critical” to reproductive, maternal and adolescent health.
She said that the dissemination provided an opportunity to review achievements, challenges and strategies for sustaining the project’s impact, while reaffirming its commitment to professional ethics and quality service delivery.
The representative of the Enugu State Primary Health Care Development Agency, Mrs Maureen Nwankwo, said the agency would sustain the gains achieved.
Nwankwo noted that the programme had helped reduce unintended pregnancies, maternal and child deaths through improved access to family planning services.
Group Director of Donor-Funded Programmes at the Society for Family Health, Mr Emeka Okafor, said the national project tested the pharmacy-led delivery model for family planning in Enugu State.
Okafor noted that while about 70 per cent of residents patronise private health providers, much of the state’s routine health data comes only from the public sector, leaving a significant gap.
He said that according to the project’s implementation report, 29,262 women accessed family planning services through trained PPMVs in Enugu State, while 14,541 referrals were made to public health facilities.
He said that the project also exceeded training targets, introduced digital supportive supervision and contributed to the institutionalisation of the Tiered Accreditation System for PPMVs.
The Pharmaceutical Society of Nigeria (PSN) and the National Association of Patent and Proprietary Medicine Dealers (NAPPMED) also pledged continued support for the initiative/project at the grassroots.
-
News2 days agoCommissioner Dies Suddenly at Abuja Hospital
-
Politics3 days ago2027: Odii: I’ll Attract ₦2tn Investment to Ebonyi in Six Months
-
News2 days agoSept. 26 Polls: ‘ENSIEC is over 90% ready’ – Chairman
-
Crime3 days agoGunmen Attack Commercial Bus, Kill Nine Passengers
-
Crime3 days agoEnugu Police Probe Alleged Disruption of Political Gatherings, Warn Against Violence
-
News3 days agoHotel Building Collapses in Enugu Kills One, Traps Workers
-
News3 days agoWhy Nigerian Leaders Should Spend Vacations at Home – Ebonyi Reps Candidate
-
Crime2 days agoKidnappers Dump 16-Year-Old Enugu Boy Near Onitsha Checkpoint, Police Rescue Him

